Joshua Cohen, Contributor

With respect to public health measures targeting Covid-19 and restarting the economy it’s not one or the other. The two work in tandem. Resolving an unfolding coronavirus public health crisis and ensuring sustained economic recovery may require a longe…

Compared to other countries, Germany remains an outlier in terms of a low coronavirus case fatality rate and minimal numbers of Covid-19 patients in serious or critical condition. Ad hoc explanations raise more questions than they answer.

Public health measures, including non-pharmaceutical interventions, are aimed at decreasing contact rates in the population and thereby reducing transmission of the virus. One such measure is systematic implementation of a nationwide lockdown.

Public health in America tends to be a patchwork of decentralized decision-making, often done in conjunction with piecemeal policies. Sometimes decision-making is carried out on the basis of federal guidance. Other times it is not.

For the purposes of driving down patient out-of-pocket costs, and also improving accountability, it may be more expeditious to subject the formulary decision-making process to more scrutiny, especially regarding Medicare Part D plans.

MedImpact’s novel program harnesses pharmacogenomics to deliver actionable results to prescribers. It does this by screening for genetic interactions with more than 240 commonly prescribed medications and notifies prescribers when a potential gene-drug…

Public health specialists assert it’s time for a much broader national dialogue about substance misuse of all drugs, licit and illicit, and that this should include alcohol.

After his campaign was left for dead, Joe Biden’s resurgence on Super Tuesday appeared to trigger a rally on Wall Street, sparked by healthcare stocks.

There is an urgent need for a multifaceted solution that encompasses a comprehensive roadmap for both development and commercialization of novel antibiotics. Here, uptake and reimbursement pose challenges for new antibiotics.

Ultimately, sales of Nexletol and Nexlizet will be driven by insurer uptake, which in turn will depend on the net price after rebates, as well as an assessment of relative cost- and clinical effectiveness.